In-hospital mortality of patients with severe bloodstream infection: only the tip of the iceberg

Affiliations

¹ Institute for Infectious Diseases and Infection Control and Centre for Sepsis Care and Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany; CAPNETZ Foundation, Hannover, Germany. Electronic address: mathias.pletz@med.uni-jena.de.
² Institute for Infectious Diseases and Infection Control and Centre for Sepsis Care and Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.
³ Institute for Infectious Diseases and Infection Control and Centre for Sepsis Care and Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany; Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.

Comment

Mathias W Pletz et al. Lancet Infect Dis. 2022 May.

. 2022 May;22(5):576-577.

doi: 10.1016/S1473-3099(21)00619-8. Epub 2022 Jan 19.

¹ Institute for Infectious Diseases and Infection Control and Centre for Sepsis Care and Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany; CAPNETZ Foundation, Hannover, Germany. Electronic address: mathias.pletz@med.uni-jena.de.
² Institute for Infectious Diseases and Infection Control and Centre for Sepsis Care and Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.
³ Institute for Infectious Diseases and Infection Control and Centre for Sepsis Care and Control, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany; Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany.

No abstract available

Conflict of interest statement

We declare no competing interests.

Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study.
Tacconelli E, Göpel S, Gladstone BP, Eisenbeis S, Hölzl F, Buhl M, Górska A, Cattaneo C, Mischnik A, Rieg S, Rohde AM, Kohlmorgen B, Falgenhauer J, Trauth J, Käding N, Kramme E, Biehl LM, Walker SV, Peter S, Gastmeier P, Chakraborty T, Vehreschild MJ, Seifert H, Rupp J, Kern WV; DZIF BLOOMY study group. Tacconelli E, et al. Lancet Infect Dis. 2022 May;22(5):731-741. doi: 10.1016/S1473-3099(21)00587-9. Epub 2022 Jan 19. Lancet Infect Dis. 2022. PMID: 35065060